UK Companies House feature
SPEMBLY MEDICAL LIMITED
Profile
- Company number
- 02087534
- Status
- Active
- Incorporation
- 1987-01-07
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 86900
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- BDO LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“On the basis of their assessment of the Company's financial position and resources, the directors have concluded that there is no intention to liquidate the Company and there is no material uncertainty with respect to the Company's going concern and that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the annual financial statements.”
Subsidiaries
- Integra NeuroSciences Limited · 100% held · United Kingdom · medical products
- Spembly Cryosurgery Limited · 100% held · United Kingdom · dormant
- Integra LifeSciences Austria GmbH · 100% held · Austria · medical products
- Integra LifeSciences Spain SL · 100% held · Spain · dormant
Significant events
- “In 2024 the Company had no trade due to changes in structure that took place in 2020.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 22 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CSC CLS (UK) LIMITED | Corporate Secretary | 2025-08-27 | — | — |
| MOSEBROOK, Jeffrey Alan | Director | 2017-11-13 | Oct 1976 | American |
| SWISS, Timothy Scott | Director | 2022-10-28 | May 1980 | American |
Show 22 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HENNEMAN III, John Bell | Secretary | 2000-04-05 | 2005-07-01 |
| HOWE, Graham John | Secretary | 1999-06-09 | 2000-04-05 |
| SINYARD, Steven Barry | Secretary | — | 1999-06-09 |
| CORPORATION SERVICE COMPANY (UK) LIMITED | Corporate Secretary | 2022-12-20 | 2025-08-27 |
| OLSWANG COSEC LIMITED | Corporate Secretary | 2005-07-01 | 2022-12-20 |
| ARDUINI, Peter Joseph | Director | 2012-02-01 | 2017-11-13 |
| CHAZANOVITZ, David Allen | Director | 1998-07-08 | 2000-04-05 |
| EMANY, Sravan Kumar | Director | 2019-02-01 | 2021-12-03 |
| ESSIG, Stuart Martin | Director | 2000-04-05 | 2012-02-01 |
| GIBSON, Peter Frederick | Director | — | 1999-02-10 |
| GLUECK, Neal Jay | Director | 2014-03-03 | 2019-01-04 |
| GORELICK, Richard Dean | Director | 2014-03-03 | 2017-11-13 |
| HENNEMAN III, John Bell | Director | 2000-04-05 | 2014-03-04 |
| HURTAK, Wenzel | Director | 2007-02-05 | 2013-03-21 |
| KNIGHT, William Joseph | Director | 1998-10-05 | 2000-04-05 |
| LEKSELL, Laurent | Director | — | 1998-07-08 |
| MARKLUND, Bjorn | Director | — | 1995-03-23 |
| PINCUS, Theodore Irwin | Director | 1998-07-08 | 1998-10-05 |
| SINYARD, Steven Barry | Director | — | 2000-04-05 |
| SPARKES, Patrick Nigel | Director | 1999-06-09 | 2007-01-31 |
| TULLY, Thomas Malcolm | Director | 1998-07-08 | 2000-04-05 |
| VON CELSING, Hans | Director | — | 1998-07-08 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Integra Lifesciences Holdings Corporation | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2023-12-23 | Active |
| Caveangle Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-12-21 | Ceased 2023-12-23 |
| Integra Neurosciences Holdings (Uk) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2020-12-21 |
Filing timeline
Last 20 of 245 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-01-09 | AD04 | address | move registers to registered office company with new address |
| 2026-01-06 | CH01 | officers | change person director company with change date |
| 2025-10-01 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-09-11 | AA | accounts | accounts with accounts type full |
| 2025-09-10 | TM02 | officers | termination secretary company with name termination date |
| 2025-09-10 | AD01 | address | change registered office address company with date old address new address |
| 2025-09-10 | AP04 | officers | appoint corporate secretary company with name date |
| 2024-10-02 | AA | accounts | accounts with accounts type full |
| 2024-09-30 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-09-16 | RP04CS01 | confirmation-statement | second filing of confirmation statement with made up date |
| 2024-09-06 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2024-09-06 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2024-05-30 | TM02 | officers | termination secretary company with name termination date |
| 2023-10-10 | AA | accounts | accounts with accounts type full |
| 2023-09-18 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-02-14 | AP04 | officers | appoint corporate secretary company with name date |
| 2023-02-09 | AD01 | address | change registered office address company with date old address new address |
| 2023-02-09 | AP01 | officers | appoint person director company with name date |
| 2023-01-08 | AA | accounts | accounts with accounts type full |
| 2022-09-22 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory